Strong Lab Automation Growth
Lab Automation delivered 35% organic sales growth, rebounding after an abnormal Q2. This showcases strong underlying demand and successful execution of the action plan to enhance processes and capabilities.
Significant Orders from Global Pharma
Biosero received orders worth USD 15.2 million from a global pharma company, indicating strong demand for Lab Automation solutions and the market-leading Green Button Go software suite.
Cash Position Strengthening
The divestments of MatTek and Visikol generated SEK 740 million, significantly strengthening BICO's cash position and resulting in a positive net cash position.
Improved EBITDA Margin
Adjusted EBITDA amounted to SEK 17 million, with a margin of 5%, reflecting improved cost control and operational efficiencies.